Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity-Reference-Cited by-同舟云学术

Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity

Published:2022-03-24 Issue:6 Volume:17 Page:1609-1616
ISSN:1828-0447
Container-title:Internal and Emergency Medicine
language:en
Short-container-title:Intern Emerg Med

Author:

Saitta Carlo^ORCID,Caruso Alessia,Maimone Sergio,Filomia Roberto,Cacciola Irene,Caccamo Gaia,Franzè Maria Stella,Pitrone Concetta,Alibrandi Angela,Gaeta Michele,Mandraffino Giuseppe,Squadrito Giovanni,Raimondo Giovanni

Publisher

Springer Science and Business Media LLC

Subject

Emergency Medicine,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11739-022-02971-5.pdf

Reference32 articles.

1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64:73–84. https://doi.org/10.1002/hep.28431

2. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M et al (2018) Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15:11–20. https://doi.org/10.1038/nrgastro.2017.109

3. Goldberg D, Ditah IC, Saeian K, Lalehzari M, Aronsohn A, Gorospe EC et al (2017) Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation. Gastroenterology 152:1090–1099. https://doi.org/10.1053/j.gastro.2017.01.003

4. Xiao G, Zhu S, Xiao X, Yan L, Yang J, Wu G (2017) Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis. Hepatology 66:1486–1501. https://doi.org/10.1002/hep.29302

5. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO) (2016) EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 64:1388–1402. https://doi.org/10.1016/j.jhep.2015.11.004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Occult Hepatitis B Virus Infection in Hepatic Diseases and Its Significance for the WHO’s Elimination Plan of Viral Hepatitis;Pathogens;2024-08-06

2. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis;BMC Medicine;2024-03-06

3. Infections as predictors of NAFLD progression;Internal and Emergency Medicine;2022-11

4. Occult Hepatitis B Virus Infection: An Update;Viruses;2022-07-08